Objective To analyze the therapeutic effects of dasatinib on testosterone propionate(TP)-induced benign prostatic hyperplasia(BPH)in animal experiments.Methods Institute of Cancer Research(ICR)mice were randomly divided into normal control group(n=5),BPH group(n=5),finasteride group(n=8),vehicle group(n=8),dasatinib intermittent administration group(n=10)and dasatinib continuous administration group(n=10).Except for the normal control group,BPH modelling was performed by subcutaneous injection of TP,and the groups were treated with saline,finasteride,polyethylene glycol 400(PEG400)and dasatinib by gavage,respectively.The mice were sacrificed after a 14-day modelling period and a 28-day administration period.The prostate and spleen were dissected,and serum was sampled.Prostate weight was measured and prostate index(PI)was calculated.HE staining was conducted on the prostate and spleen,and Ki-67 immunohistochemical staining was performed on the prostate.Differences in the levels of serum dihydrotestosterone(DHT)and prostate-specific antigen(PSA)were detected with ELISA.Results The prostate weight and PI were significantly reduced in the dasatinib intermittent and continuous administration groups than in the BPH group(P<0.000 1),and the serum DHT level was also significantly reduced(P<0.01),but there were no significant differences in prostate weight,PI and serum DHT between dasatinib intermittent and continuous administration groups(P>0.05),and no significant difference in PSA level among the three groups(P>0.05).After dasatinib treatment,the pathological manifestations of prostate glandular and interstitial hyperplasia were significantly improved;the positive rate of Ki-67 was lower in the dasatinib intermittent and continuous administration groups than in the BPH group(P<0.001).Conclusion Dasatinib can inhibit TP-induced BPH,reduce serum DHT level,and inhibit the proliferation of prostate glandular and interstitial cells in mice.The therapeutic effects of intermittent administration of dasatinib are consistent with those of continuous administration.